Dexcom [DXCM] vs Stryker [SYK] Detailed Stock Comparison

Dexcom Inc.

NASDAQ
Loading...

Stryker Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Dexcom Inc. wins in 9 metrics, Stryker Corporation wins in 11 metrics, with 0 ties. Stryker Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Dexcom Inc. Stryker Corporation Better
P/E Ratio (TTM) 30.03 39.21 Dexcom Inc.
Price-to-Book Ratio 8.63 5.62 Stryker Corporation
Debt-to-Equity Ratio 50.85 72.97 Dexcom Inc.
PEG Ratio 0.39 0.72 Dexcom Inc.
EV/EBITDA 19.85 19.90 Dexcom Inc.
Profit Margin (TTM) 17.94% 12.92% Dexcom Inc.
Operating Margin (TTM) 25.64% 27.24% Stryker Corporation
EBITDA Margin (TTM) 25.64% 27.24% Stryker Corporation
Return on Equity 34.50% 15.08% Dexcom Inc.
Return on Assets (TTM) 8.89% 7.92% Dexcom Inc.
Free Cash Flow (TTM) $1.08B $4.28B Stryker Corporation
Dividend Yield N/A 0.97% N/A
1-Year Return -14.06% -20.27% Dexcom Inc.
Price-to-Sales Ratio (TTM) 5.10 5.02 Stryker Corporation
Enterprise Value $23.09B $138.30B Stryker Corporation
EV/Revenue Ratio 4.95 5.51 Dexcom Inc.
Gross Profit Margin (TTM) 62.93% 64.54% Stryker Corporation
Revenue per Share (TTM) $12 $66 Stryker Corporation
Earnings per Share (Diluted) $2.05 $8.40 Stryker Corporation
Beta (Stock Volatility) 1.56 0.93 Stryker Corporation
Short % of Float 4.93% 1.20% Stryker Corporation

Dexcom Inc. vs Stryker Corporation Stock Performance Analysis

Loading Price Chart...

DXCM
SYK

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dexcom Inc.-0.93%2.00%22.34%-0.45%13.96%10.38%
Stryker Corporation0.58%-6.29%0.83%-24.22%-20.01%-15.76%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dexcom Inc.-14.06%-39.84%-22.97%336.85%1,920.27%1,293.95%
Stryker Corporation-20.27%9.63%21.15%168.66%406.79%583.29%

Performance & Financial Health Analysis: Dexcom Inc. vs Stryker Corporation

MetricDXCMSYK
Market Information
Market Cap i$23.76B$126.25B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i4,652,6041,881,406
90 Day Avg. Volume i4,100,8482,161,139
Last Close$72.77$295.00
52 Week Range$54.11 - $89.98$281.00 - $404.87
% from 52W High-19.13%-27.14%
All-Time High$164.86 (Nov 15, 2021)$406.19 (Jan 27, 2025)
% from All-Time High-55.86%-27.37%
Growth Metrics
Quarterly Revenue Growth0.13%0.11%
Quarterly Earnings Growth0.76%0.56%
Financial Health
Profit Margin (TTM) i0.18%0.13%
Operating Margin (TTM) i0.26%0.27%
Return on Equity (TTM) i0.35%0.15%
Debt to Equity (MRQ) i50.8572.97
Cash & Liquidity
Book Value per Share (MRQ)$7.14$58.61
Cash per Share (MRQ)$5.19$10.71
Operating Cash Flow (TTM) i$1.44B$5.04B
Levered Free Cash Flow (TTM) i$719.54M$4.17B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend iN/A$3.40

Valuation & Enterprise Metrics Analysis: Dexcom Inc. vs Stryker Corporation

MetricDXCM (Apr 26, 2026)SYK (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i30.0339.21
Forward P/E i20.5919.67
PEG Ratio i0.390.72
Price to Sales (TTM) i5.105.02
Price to Book (MRQ) i8.635.62
Market Capitalization
Market Capitalization i$23.76B$126.25B
Enterprise Value i$23.09B$138.30B
Enterprise Value Metrics
Enterprise to Revenue i4.955.51
Enterprise to EBITDA i19.8519.90
Risk & Other Metrics
Beta i1.560.93
Book Value per Share (MRQ) i$7.14$58.61

Financial Statements Comparison: Dexcom Inc. vs Stryker Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricDXCM (2025)SYK (2025)
Revenue/Sales i4.66B25.12B
Cost of Goods Sold i1.86B9.05B
COGS % of Revenue i39.9%36.0%
Gross Profit i2.80B16.07B
Gross Margin i60.1%64.0%
Research & Development i599.10M1.62B
Operating Income (EBIT) i911.80M5.06B
Operating Margin i19.6%20.1%
EBITDA i1.36B6.48B
EBITDA Margin i29.1%25.8%
Pre-Tax Income i1.09B4.51B
Pre-Tax Income % of Revenue i23.3%18.0%
Income Tax i252.10M1.27B
Income Tax % of Revenue i5.4%5.0%
Net Income (Profit) i836.30M3.25B
Profit Margin i17.9%12.9%

Balance Sheet & Liquidity Metrics

MetricDXCM (2025)SYK (2025)
Cash & Equivalents i917.70M4.01B
Total Current Assets i4.03B14.76B
Total Current Assets % of Revenue i86.5%58.7%
Total Current Liabilities i2.14B7.79B
Total Current Liabilities % of Revenue i46.0%31.0%
Long-Term Debt i1.37B14.86B
Long-Term Debt % of Revenue i29.3%59.2%
Total Shareholders Equity i2.75B22.42B
Retained Earnings i2.43B20.47B
Retained Earnings % of Revenue i52.2%81.5%
Property, Plant & Equipment i77.40M1.79B

Cash Flow Statement Comparison

MetricDXCM (2025)SYK (2025)
Operating Cash Flow i1.48B4.70B
Operating Cash Flow % of Revenue i31.7%18.7%
Capital Expenditures i-363.50M-761.00M
Free Cash Flow i1.08B4.28B
FCF Margin i23.1%17.1%
Debt Repayment i-1.21B-1.40B
Common Stock Repurchase i-500.00MN/A

Short Interest & Institutional Ownership Analysis

MetricDXCMSYK
Shares Short i14.72M4.42M
Short Ratio i3.771.95
Short % of Float i4.93%1.20%
Shares Outstanding i384.80M382.50M
Float Shares i382.94M346.55M
% Held by Insiders i0.28%5.37%
% Held by Institutions i101.50%82.09%
% Held by Public i-1.78%12.54%

Dividend Analysis & Yield Comparison: Dexcom Inc. vs Stryker Corporation

MetricDXCMSYK
Last 12-Month Dividend iN/A$3.40
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend iN/A$3.23
3-Year Avg Dividend Yield iN/A0.24%
3-Year Total Dividends iN/A$9.69
Ex-Dividend DateN/ADec 31, 2025